# Sources — Lorraine Hansberry

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. PBS / WNET. “Lorraine Hansberry Biographical Timeline,” *American Masters: Lorraine Hansberry: Sighted Eyes/Feeling Heart*, January 11, 2018. Supports her birth in Chicago on May 19, 1930, to Carl Augustus Hansberry, Sr. and Nannie Louise Hansberry; the family’s move into Washington Park in 1937 and Hansberry v. Lee in 1940; her father’s sudden death in Mexico in 1946 of a cerebral hemorrhage; the University of Wisconsin (1948) and the move to New York (1950); her marriage to Robert Nemiroff in June 1953 and a divorce obtained in Mexico in 1964; the move to Croton-on-Hudson in 1962; in 1963 an attack in which she collapsed in pain, a ten-day admission in which doctors diagnosed cancer while she was told she had anemia and bleeding ulcers, an unsuccessful operation in New York in June, and surgery at the Lahey Clinic at the New England Baptist Hospital in Boston in August; the To Be Young, Gifted, and Black speech in May 1964 on an afternoon out of hospital, the Town Hall debate in June 1964, and the opening of *The Sign in Sidney Brustein’s Window* in October 1964; and her death “of cancer of the duodenum at the age of 34 at University Hospital” on January 12, 1965. https://www.pbs.org/wnet/americanmasters/lorraine-hansberry-sighted-eyes-feeling-heart-timeline/9879/
2. Harris J. “Hansberry, Lorraine Vivian.” *Scribner Encyclopedia of American Lives, Thematic Series: The 1960s*, via Encyclopedia.com. Supports her parents Carl Augustus and Nannie Perry and her father’s bank; Hansberry v. Lee (November 12, 1940); her marriage on June 20, 1953; *A Raisin in the Sun* as the first play by an African-American woman on Broadway; and a cancer diagnosis in 1963. https://www.encyclopedia.com/humanities/encyclopedias-almanacs-transcripts-and-maps/hansberry-lorraine-vivian
3. Powers N. “Hansberry, Lorraine (1930–1965).” *Women in World History: A Biographical Encyclopedia* (Gale), via Encyclopedia.com. Supports the onset in April 1963 of fainting spells and attacks of nausea, at first suspected to be a duodenal ulcer, “later discovered to be colon cancer that had spread to her pancreas”; her work on *The Sign in Sidney Brustein’s Window* as her health failed; her admission to New York’s University Hospital; and her death on January 12, 1965. https://www.encyclopedia.com/women/dictionaries-thesauruses-pictures-and-press-releases/hansberry-lorraine-1930-1965
4. Wikipedia. “Lorraine Hansberry.” Used for the opening of *A Raisin in the Sun* at the Ethel Barrymore Theatre on March 11, 1959, the dates of the two operations (June 24 and August 2, 1963), the funeral in Harlem on January 15, 1965, and as a pointer to its sources. https://en.wikipedia.org/wiki/Lorraine_Hansberry
5. Biography.com. “Lorraine Hansberry” (updated August 16, 2023). Supports her place as the youngest of four children, her grandfather born enslaved, the Broadway opening and her award at 29, a divorce in 1962, and a diagnosis of pancreatic cancer in 1964. https://www.biography.com/writer/lorraine-hansberry
6. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026). Pancreas-protocol imaging, EUS-guided biopsy, biliary drainage with a metal stent before chemotherapy, CA 19-9 after the bilirubin is normal, resectability criteria (borderline resectable for venous contact over 180 degrees), multidisciplinary review, germline testing for every patient and tumor molecular profiling, modified FOLFIRINOX for fit patients, chemotherapy before surgery for borderline resectable disease, enzyme replacement, palliative care, and surveillance. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455
2. Khorana AA, et al. “Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.” *J Clin Oncol* 2016;34(21):2541–2556 (PMID 27247221), and the 2019 update (*J Clin Oncol* 2019;37(23):2082–2088, PMID 31180816). Multidisciplinary review, preoperative therapy for borderline resectable disease, about six months of chemotherapy in all, and modified FOLFIRINOX at the doses used here. https://pubmed.ncbi.nlm.nih.gov/27247221/ and https://pubmed.ncbi.nlm.nih.gov/31180816/
3. Sohal DPS, et al. “Metastatic Pancreatic Cancer: ASCO Guideline Update.” *J Clin Oncol* 2020;38(27):3217–3230 (PMID 32755482). Cited for tumor molecular testing (mismatch repair, NTRK and other actionable alterations); the patient does not have metastatic disease. https://pubmed.ncbi.nlm.nih.gov/32755482/
4. Stoffel EM, et al. “Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.” *J Clin Oncol* 2019;37(2):153–164 (PMID 30457921). Germline genetic testing for all patients with pancreatic adenocarcinoma, whatever the family history. https://pubmed.ncbi.nlm.nih.gov/30457921/
5. Sanders JJ, et al. “Palliative Care for Patients With Cancer: ASCO Guideline Update.” *J Clin Oncol* 2024;42(19):2336–2357 (PMID 38748941). Specialist palliative care early, alongside cancer treatment, for patients with advanced or high-symptom-burden cancer. https://pubmed.ncbi.nlm.nih.gov/38748941/
6. Key NS, et al. “Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update.” *J Clin Oncol* 2023;41(16):3063–3071 (PMID 37075273), with the AVERT trial (Carrier M, et al. *N Engl J Med* 2019;380(8):711–719, PMID 30511879). Apixaban, rivaroxaban or low-molecular-weight heparin offered to ambulatory patients with a Khorana score of 2 or more without a high bleeding risk; extended prophylaxis after major abdominal cancer surgery. https://pubmed.ncbi.nlm.nih.gov/37075273/
7. Hesketh PJ, et al. “Antiemetics: ASCO Guideline Update.” *J Clin Oncol* 2020;38(24):2782–2797 (PMID 32658626). https://pubmed.ncbi.nlm.nih.gov/32658626/
8. Loprinzi CL, et al. “Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.” *J Clin Oncol* 2020;38(28):3325–3348 (PMID 32663120). https://pubmed.ncbi.nlm.nih.gov/32663120/
9. Hwang JP, et al. “Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.” *J Clin Oncol* 2020;38(31):3698–3715 (PMID 32716741). https://pubmed.ncbi.nlm.nih.gov/32716741/
10. Oktay K, et al. “Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.” *J Clin Oncol* 2018;36(19):1994–2001 (PMID 29620997). Fertility discussion before gonadotoxic treatment. https://pubmed.ncbi.nlm.nih.gov/29620997/
11. Benson AB 3rd, et al. “Recommended guidelines for the treatment of cancer treatment-induced diarrhea.” *J Clin Oncol* 2004;22(14):2918–2926 (PMID 15254061). High-dose loperamide and escalation for complicated diarrhea (used at the sick visit). https://pubmed.ncbi.nlm.nih.gov/15254061/
12. American Diabetes Association. Standards of Care in Diabetes—2026 (classification, including diabetes of the exocrine pancreas; eye, kidney and foot screening). https://diabetesjournals.org/care/issue/49/Supplement_1
13. CMID: Clinical Monitoring Intelligence Database, diabetes mellitus (type 2) and anemia monographs (Aether Forge, 2026), used for the cadence of A1c, kidney, eye and foot checks and for ferritin after iron. https://patrickrutledge.github.io/topthirty/
14. Equity: Noel M, Fiscella K. “Disparities in Pancreatic Cancer Treatment and Outcomes.” *Health Equity* 2019;3(1):532–540 (PMID 31663065): African Americans present at a later stage and have lower rates of surgical resection. Dhali A, et al. *Am J Clin Oncol* 2026 (PMID 41996299): in SEER data, Black patients had worse survival, lower odds of surgery and longer time to treatment. https://pubmed.ncbi.nlm.nih.gov/31663065/ and https://pubmed.ncbi.nlm.nih.gov/41996299/
15. U.S. Preventive Services Task Force: depression (2023), cervical cancer (2018), intimate partner violence (2018), unhealthy alcohol use (2018), and the A and B recommendations; Centers for Disease Control and Prevention, Adult Immunization Schedule by Medical Condition; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations, https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html, https://patrickrutledge.github.io/preventative_services/

The CMID has no pancreatic cancer monograph, so the specialty guidelines above govern the cancer monitoring.

## Editorial resolutions

- **Recent-death rule.** She died in 1965, so the rule does not apply. The claims are still limited to what the fetched sources state. The New York Times obituary, the Library of Congress pages and the Lorraine Hansberry Literary Trust site could not be fetched (blocked or moved), and Imani Perry’s *Looking for Lorraine* was not read and no reliable quotation of its medical account was found; none of them is cited.
- **The site of her cancer (R).** Most reference works and Biography.com say pancreatic cancer; the PBS American Masters timeline says cancer of the duodenum; Women in World History says colon cancer that had spread to the pancreas. No pathology was found. The conflict is recorded as **R**, disputed (CLM-0011), linked to the modern diagnosis but not resolved by it. The modern episode uses a pancreatic head adenocarcinoma invading the duodenum, which fits both the pancreatic and the duodenal accounts and the documented bleeding “ulcers”; this is a teaching choice.
- **Date of diagnosis.** PBS, the Scribner encyclopedia and Wikipedia put the diagnosis in 1963; Biography.com says 1964. Women in World History dates the first fainting spells and nausea to April 1963. 1963 is preferred because three sources agree and the documented operations of June and August 1963 require it.
- **Index age and dates.** The synthetic date of birth is May 19, 1993 (shift 63 years). The index visit on April 20, 2026 maps to April 20, 1963, when she was 32, in the month Women in World History gives for the first symptoms and before the collapse and admission. The assignment suggested about 33; 32 was used because she turned 33 only in May 1963, after the documented onset, and an index age of 33 would place the presentation after it. All visits map to April to October 1963, within her lifetime; they are not a claim about where she was. The operation on August 24, 2026 maps to the month of her documented surgery in Boston, which it does not claim to describe.
- **Intake claims.** The April 1963 onset (CLM-0006) is shown at intake; the collapse, admission and diagnosis (CLM-0007) and the operations (CLM-0008) are linked to a timeline event dated “by June 1963,” because PBS gives no month for the collapse and it preceded the June operation, so they do not appear in the intake documents.
- **Disclosure.** PBS records that she was told she had anemia and bleeding ulcers while her doctors diagnosed cancer. The record states this as history only and attributes no modern decision to anyone; in the modern episode the diagnosis, stage and aim of treatment are explained to her plainly, at her request, which is the intended contrast.
- **Presenting problem.** Epigastric pain with weight loss (R10.13) and new hyperglycemia (R73.09) are resolved at the diagnosis visit on May 4, 2026, when pancreatic head adenocarcinoma (C25.0, both_with_link), diabetes due to the cancer (E08.9), exocrine insufficiency (K86.81), cancer pain (G89.3) and bile duct obstruction (K83.1) are recorded. Iron deficiency anemia from blood loss (D50.0) is recorded at intake and stays active. The intake documents state only what was known then.
- **Synthetic clinical picture.** All visits, results, imaging, pathology, stage (borderline resectable), the regimen and doses (modified FOLFIRINOX for six cycles at a body surface area of 1.58 m2, then six cycles of fluorouracil, leucovorin and irinotecan), the genetic and tumor results (germline negative; KRAS G12D, microsatellite stable), the operation and its pathology (ypT2N1, R0), her height (163 cm) and weights are synthetic. Qualitative results (biopsies, hepatitis and HIV tests, pregnancy test, genetic results, stool C. difficile test) are in note text only.
- **Germline result.** The germline panel is negative by design: a positive result would imply a health fact about her real blood relatives. The plan states that cascade testing would follow only if a variant were found.
- **Fertility.** The record has her decline egg or embryo freezing so that chemotherapy is not delayed. This is a synthetic choice for teaching, not a claim about her real wishes about children.
- **Private relationships.** Her documented marriage is recorded as the sources state it, with the conflict over the year of divorce (1962 or 1964). The Scribner encyclopedia also documents that she wrote to the lesbian periodical *The Ladder*; it is not used, because it is not needed for this episode’s social history. The modern episode gives no partner, relative or friend a role; her health care agent is unnamed.
- **Equity.** The teaching objective and the intake plan cite the documented disparities in pancreatic cancer care for Black Americans (later diagnosis, less surgery, longer time to treatment). The urgent care visit that called her pain indigestion and stress is synthetic and is not a claim about her real care.
- **Sick visit.** Grade 2 irinotecan diarrhea on day 4 of cycle 5 (K52.1), chosen because it is a common, expected effect of her regimen, interacts with her enzyme replacement, diabetes and electrolytes, and insinuates no undocumented real diagnosis. It was treated with fluids, potassium, magnesium and loperamide, and irinotecan was reduced by one dose level.
- **Preventive visit.** A periodic adult preventive visit at 33 (CPT 99395 and 99497 in plain text) during chemotherapy after surgery: influenza and COVID-19 vaccines between cycles; PCV20 and both recombinant zoster doses already given before and during chemotherapy; cervical screening due and planned after chemotherapy at her choice (recorded as due, since the schema has no deferred status for prevention items); hepatitis B vaccination after chemotherapy; contraception without estrogen; and advance care planning with an unnamed agent.
- **Focused visits.** The four chronic-care follow-ups (diagnosis and consultation, cycle 4, after six cycles, and six weeks after surgery) are documented as focused visits on the NCCN pancreatic guideline, the ASCO guidance listed above, the ADA Standards and the CMID diabetes and anemia monographs. Synthetic findings introduced: oxaliplatin neuropathy (G62.0) at cycle 4, and acquired partial absence of the pancreas (Z90.411) after surgery. Two protocol deviations are recorded instead of invented results: (1) the dilated eye examination and urine albumin-to-creatinine ratio due when diabetes was diagnosed were not arranged; recorded at cycle 4 and after six cycles, no harm expected, the urine test done after surgery (12 mg/g) and the eye examination the following week (normal, reported at the preventive visit); (2) the interim CT ordered at cycle 4 was never scheduled; no harm, since CA 19-9 kept falling and the CT after six cycles showed a response; corrective action: imaging orders tracked by the nurse navigator.
- **Thromboprophylaxis.** Her Khorana score was 3, but apixaban was held at diagnosis because the duodenal tumor had bled, and started at cycle 4 after eight weeks without bleeding. This timing is a clinical judgment call for review.
- **Consultation.** The medical oncology referral and the consultation by Samuel Adeyemi-Rourke, MD (a fictional consultant), on the diagnosis day, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: borderline resectable disease; six cycles of modified FOLFIRINOX, then pancreaticoduodenectomy with vein resection (R0), then chemotherapy after surgery; germline and tumor testing; palliative care, enzyme replacement and low-dose opioid; insulin after surgery; apixaban once bleeding settled and enoxaparin after surgery; and fertility counseling. His recommendation of an interim CT after four cycles was not carried out, as the visit after six cycles records.
- **Real people.** Robert Nemiroff appears only in the claims. No relative, friend, collaborator or historical physician is given a role in the modern episode, and no other figure with a record in the dataset is named.
- **Not used.** Her father’s first name is given as Charles in Women in World History and as Carl Augustus elsewhere; Carl is used. That source also gives her age at death as 35; she was 34. Accounts that her husband and doctors kept the diagnosis from her (found only on low-quality sites) are not claimed beyond the PBS statement. Her smoking, alcohol use and private papers were not researched.
